<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="85.039,88.958,93.907,97.359,102.308,106.227,110.71,113.131,118.771,122.689,127.638,130.059,132.946,137.896,141.814,144.235,146.656,151.605,156.555,161.038,163.925,168.874,173.357,175.778,179.697,183.149,188.098,191.55,193.971,198.92,203.87,207.322,209.743,215.485,222.389,224.81,229.293,233.211,238.16000000000003,243.831,246.718,251.667,255.585,261.235,264.687,272.058,276.541,278.962,281.383,287.03,291.979,296.928,304.299,309.248,313.166,316.618,322.291,327.241" y="500.038" svg_rhmargin="330.128" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">corneal epitheliopathy/erosions. Given the small number of</text>
  <text x="85.039,88.491,91.379,96.328,101.277,103.698,107.617,111.069,117.523,122.007,126.956,131.905,138.33,141.782,146.731,151.681,155.133,158.02,162.503,167.452,170.339,172.76,177.243,179.664,186.12,191.069,194.988,197.875,201.793,205.245,210.195,214.678,218.596,223.545,227.464,229.885,232.772,237.255,243.775,248.725,251.612,258.061,262.544,267.494,271.977,275.895,279.347,282.799,286.717,293.154,297.072,301.555,305.473,310.423,313.31,316.762,319.183,325.638" y="510.979" svg_rhmargin="330.121" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">studies and substantial heterogeneity of adverse events, a</text>
  <text x="85.039,88.491,93.441,98.39,102.873,106.325,111.275,116.224,121.173,124.157,128.64,133.589,138.072,140.493,144.976,148.428,150.849,154.301,157.321,164.225,168.708,172.16,175.179,180.129,185.078,187.965,190.939,195.889,199.807,203.259,206.146,211.096,214.548,221.918,225.836,230.786" y="521.921" svg_rhmargin="233.207" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">subgroup analysis was not performed.</text>
  <text x="93.997,99.879,104.828,108.74600000000001,111.855,115.307,119.79,122.677,126.596,129.483,133.966,137.083,142.032,144.919,147.968,152.917,155.338,158.225,161.112,165.03,168.482,172.401,177.35,180.237,183.4,188.349,193.299,196.751,201.234,205.717,209.635,213.087,216.167,221.116,224.00300000000001,227.109,231.592,236.541,239.428,241.849,244.736,251.174,256.59,263.494,268.44300000000004,271.555,276.038,280.521,284.439,289.389,292.276,295.365,302.269,306.752,310.204,313.279,318.229,323.178,325.599" y="532.919" svg_rhmargin="330.082" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The safety of different dosages of anti-VEGF agent was only</text>
  <text x="85.039,87.46,92.41,96.893,100.811,104.263,107.15,109.571,114.054,118.537,121.425,125.343,130.292,133.794,136.215,141.16400000000002,144.679,147.566,152.515,156.433,159.872,164.822,168.74,173.689,176.11,180.593,184.045,187.538,189.959,194.908,197.795,202.745,205.165,209.084,212.536,217.019,221.968,225.887,229.805,233.344,237.827,242.776,247.72500000000002,251.202,255.12,260.07,265.019,267.44,272.389,277.339,281.257,284.144,286.565,291.048,295.531,297.952,301.43,305.913,310.863,315.346,319.264,322.716,326.168" y="543.861" svg_rhmargin="330.086" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">investigated in the ocular intolerance and conjunctival adverse</text>
  <text x="85.039,88.958,93.441,97.359,102.308,105.196,107.617,109.813,114.296,117.748,119.905,122.792,127.741,131.659,133.851,136.272,138.693,146.063,148.484,151.371,155.289,160.238,162.48,165.932,168.82,173.769,178.718,181.139,185.058,188.51,190.656,194.108,198.026,202.976,207.925,211.377,214.264,218.183,223.132,225.351,228.238,233.188,237.106,239.297,243.781,248.73,253.213,257.131,260.583,264.035,267.95300000000003,270.137,274.055,278.538,282.457,287.406,290.293,292.473,294.894,299.843,301.997,305.915,310.865,314.317,319.266,323.184,327.668" y="554.802" svg_rhmargin="330.089" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">event, as the limited studies reported the adverse event in cornea.</text>
  <text x="85.039,87.927,92.876,95.471,100.42,105.37,108.822,111.345,113.766,118.715,122.633,125.054,130.004,134.953,138.871,143.82000000000002,146.436,152.874,159.312,165.194,168.646,171.06699999999998,173.648,176.535,181.484,185.40200000000002,187.934,192.883,197.833,201.285,205.768,210.251,214.169,216.733,221.682,224.569,227.164,231.647,236.597,239.484,241.905,244.792,251.23,256.645,263.549,268.498,271.1,273.521,276.973,279.547,284.49600000000004,285.613,292.983,297.466,299.887,307.258,312.673,315.206,317.627,322.576,325.184" y="565.744" svg_rhmargin="330.133" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">In our included RCTs, the dosage of anti-VEGF is 5 mg/mL in 2</text>
  <text x="85.039,88.491,91.379,96.328,101.277,103.698,107.617,111.069,113.49000000000001,117.07,122.019,126.968,129.389,134.33800000000002,135.495,142.865,147.348,149.769,157.139,162.554,166.108,168.529,173.478,177.05,181.99900000000002,185.553,189.005,191.893,196.842,201.791,204.212,208.131,211.583,214.004,217.64,222.59,227.53900000000002,228.638,236.009,240.492,242.913,250.283,255.69799999999998,259.308,261.729,266.678,270.25,275.199,280.148,283.686,287.138,290.025,294.975,299.924,302.345,306.263,309.715,312.13599999999997,315.716,320.199,325.149" y="576.742" svg_rhmargin="330.098" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">studies, 12.5 mg/mL in 3 studies, 25 mg/mL in 10 studies, and</text>
  <text x="85.039,89.989,94.938,98.856,101.277,105.196,109.679,113.131,116.276,118.697,123.646,126.821,129.708,134.657,138.57500000000002,141.731,146.68,149.567,154.517,158.435,161.887,165.03,169.979,173.138,176.59,179.477,184.426,189.376,191.797,195.715,199.167,201.588,204.772,207.659,212.608,215.77,218.657,223.606,227.524,230.68,235.629,239.548,244.497,246.918,251.401,254.853,258.005,260.426,265.375,268.262,273.212,275.632,279.551,283.003,287.486,292.435,296.354,300.272,302.693,305.852,310.335,312.756,315.17699999999996,318.324,321.211,326.16" y="587.683" svg_rhmargin="330.078" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">unclear in the other 3 studies. In the ocular intolerance, all the</text>
  <text x="85.039,88.491,91.379,96.328,101.277,103.698,107.617,111.069,114.065,117.517,121.435,126.385,131.334,134.786,137.673,141.592,146.54100000000003,149.554,152.441,157.39,161.308,164.35,169.299,173.218,178.167,180.588,185.071,188.523,191.505,193.926,198.876,201.763,206.712,209.133,213.051,216.503,220.986,225.936,229.854,233.77200000000002,236.801,240.719,245.203,249.121,254.07,256.957,260.409,263.446,267.93,272.879,280.249,282.67,287.62,290.04,293.492,296.38,299.832,304.315,307.202,311.12,316.069,319.117,324.067" y="598.625" svg_rhmargin="329.016" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">studies reported the ocular intolerance events administrated 25</text>
  <text x="85.039,92.41,96.893,99.314,106.684,112.1,114.521,118.034,123.449,127.367,131.286,135.769,140.718,144.17,148.088,151.652,156.601,159.488,162.991,165.878,170.827,174.745,178.297,182.78,187.263,190.715,193.136,198.086,203.035,206.487,209.987,214.471,219.42,223.903,227.821,231.273,234.726,238.644,242.188,246.106,250.59,254.508,259.457,262.344,265.796,269.286,271.707,276.656,280.171,285.121,288.008,292.957,296.875,300.327,303.868,308.818,313.767,317.219,321.702,326.185" y="609.623" svg_rhmargin="330.103" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">mg/mL. Because of the various adverse events in other dosage</text>
  <text x="85.039,89.523,94.472,99.421,101.842,104.263,108.181,112.665,115.552,117.973,122.922,127.871,131.323,133.744,135.437,138.889,143.839,148.788,153.271,156.723,161.673,166.622,171.57100000000003,173.25,177.733,182.682,187.166,189.586,194.07,197.522,199.943,203.395,205.11,210.059,212.946,214.634,218.552,223.502,228.451,230.872,235.821,240.771,244.689,247.576,249.997,254.48,258.963,261.384,263.105,267.588,272.537,277.02,280.939,284.391,287.843,291.761,293.434,297.352,301.836,305.754,310.703,313.59,315.26,322.164,326.647" y="620.565" svg_rhmargin="330.099" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">applications, subgroup analysis of conjunctival adverse event was</text>
  <text x="85.039,89.989,93.907,97.359,100.246,105.196,108.648,116.018,119.936,124.885,128.634,131.055,136.00400000000002,139.69,142.577,147.526,151.44400000000002,155.167,158.619,161.506,166.455,171.405,173.826,177.744,181.196,184.929,191.833,194.254,197.141,202.09,205.849,210.798,215.747,216.847,224.217,228.7,231.121,238.491,243.906,247.63,252.113,257.062,259.95,262.37,265.258,271.695,277.111,284.015,288.964,291.385,295.137,301.575,306.524,311.473,315.206,317.627,320.514,324.22,326.641" y="631.506" svg_rhmargin="330.093" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">performed in the studies with 25 mg/mL anti-VEGF. And it is</text>
  <text x="85.039,88.491,93.441,97.924,102.407,106.325,109.777,112.665,116.583,121.532,123.986,126.873,131.823,136.306,139.193,141.618,146.101,151.05,153.937,156.358,159.245,165.683,171.099,178.003,182.952,185.383,189.866,193.318,198.268,203.217,208.16600000000003,210.611,213.032,216.484,218.945,222.397,224.818,229.301,234.25" y="642.504" svg_rhmargin="236.671" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">suggested that anti-VEGF group is signi</text>
  <text x="236.637" y="642.504" svg_rhmargin="241.586" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="241.626,245.544,250.027,254.977,257.864,260.285,264.76800000000003,267.193,274.564,279.513,282.965,286.883,289.303,294.253,299.202,302.654,306.106,308.527,313.477,315.897,319.815,322.298,325.185" y="642.504" svg_rhmargin="330.134" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cantly more possible to</text>
  <text x="85.039,89.523,93.441,96.328,98.532,102.45,107.4,112.349,114.77,119.719,124.669,128.587,131.474,133.895,138.378,142.861,145.28199999999998,147.569,152.053,157.002,161.485,165.403,168.855,172.307,176.225,178.409,182.327,186.81,190.729,195.678,198.565,200.802,203.69,208.639,213.122,218.07100000000003,220.304,223.191,228.141,232.059,234.307,238.225,243.174,248.124,251.011,254.463,259.412,261.83299999999997,264.07,268.553,272.005,276.954,281.904,286.853,289.07,291.957,299.328,305.766,308.187,310.386,315.335,317.756,322.706,327.655" y="653.446" svg_rhmargin="330.076" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">get conjunctival adverse event than the control group (OR: 0.91;</text>
  <text x="85.039,89.989,94.938,103.904,106.866,113.304,116.191,118.61200000000001,121.662,126.612,129.033,133.982" y="664.387" svg_rhmargin="138.931" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">95% CI, 1.04</text>
  <text x="138.898" y="664.387" svg_rhmargin="143.381" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:8.97px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="163.067" x="143.377,148.326,150.747,155.697,160.646,163.06699999999998" y="664.387" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">3.52; </text>
  <text svg_rhmargin="171.527" x="166.111,171.52599999999998" y="664.387" style="fill:#171615;font-family:DPNDOJ+AdvOT638a931c.I;font-size:8.97px;font-style:NORMAL;font-weight:normal;">P </text>
  <text x="172.63" y="664.387" svg_rhmargin="178.7" style="fill:#171615;font-family:DPNDGB+AdvOTb0c9bf5d;font-size:8.97px;font-style:NORMAL;font-weight:normal;">=</text>
  <text x="179.83,182.251,187.201,192.15,195.037,198.028,200.915,205.865,208.286,212.769,215.19,218.206,223.155" y="664.387" svg_rhmargin="226.042" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">.04) (Fig. 5)</text>
  <text x="85.039,90.955,93.908,98.646,105.744,108.498,113.723,119.241,125.156,130.381,135.605,138.359,144.076" y="691.0360000000001" svg_rhmargin="149.991" style="fill:#171615;font-family:DPNDFJ+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">4. Discussion</text>
  <text x="85.039,90.921,95.871,98.292,101.744,103.974,107.426,110.314,115.263,120.212,124.69500000000001,126.934,129.355,134.305,138.223,140.644,145.593,150.543,154.461,159.41000000000003,161.686,166.635,171.584,173.818,180.256,186.694,192.576,196.028,198.309,205.213,207.634,210.521,215.47,217.698,222.647,227.596,232.546,237.495,239.75,243.669,248.152,252.07,255.522,257.943,260.159,266.041,270.991,274.909,277.167,282.116,287.065,292.015,294.436,298.354,303.303,305.569,309.021,312.939,316.392,321.341,323.762,326.649" y="706.967" svg_rhmargin="330.101" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">This study included 18 RCTs with 1406 eyes. The pooled results</text>
  <text svg_rhmargin="330.082" x="85.039,89.989,92.876,94.677,97.564,102.514,106.432,108.226,111.678,114.565,119.515,124.464,126.885,130.803,134.255,136.061,139.513,144.463,148.946,153.429,157.347,160.799,163.686,165.541,168.428,173.377,177.86,180.747,182.548,187.497,190.949,194.86700000000002,196.664,201.614,204.501,206.302,210.785,215.734,217.527,222.01,226.96,229.847,232.268,235.155,241.593,247.008,253.913,258.862,260.67,265.153,269.636,273.554,278.504,281.391,283.176,285.597,290.546,292.36,295.247,300.197,304.115,305.909,310.858,314.777,319.726,322.147,326.63,330.082" y="500.036" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">of the studies suggest that use of an anti-VEGF agent in the ocular </text>
  <text x="345.091,349.574,354.523,357.41,361.329,364.781,367.202,372.151,375.603,379.219,382.671,386.59,391.073,398.443,402.361,407.311,410.198,413.8,416.688,421.637,425.089,428.711,433.66,438.143,441.03,443.451,447.369,452.319,455.206,458.658,462.271,469.175,471.596,474.484,479.433,483.078,488.027,490.914,494.833,498.285,502.768,507.251,509.672,514.621,521.991,525.596,530.079,535.028,539.977,543.567,548.05,550.471,554.954,559.904,563.822,568.771,576.142,580.625,584.271,586.692" y="500.036" svg_rhmargin="590.144" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">anterior segment for patients with pterygium and glaucoma is</text>
  <text x="345.091,349.574,353.492,358.442,362.36,365.812,370.295,372.716,375.137,379.62,382.62,386.072,390.555,393.442,397.361" y="510.978" svg_rhmargin="399.782" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">generally safe.</text>
  <text x="354.048,359.93,364.879,367.3,370.752,374.117,377.569,381.487,384.939,389.888,392.309,395.196,398.607,405.511,409.994,413.446,416.862,420.78,425.729,430.679,434.131,436.552,440.004,442.891,446.809,451.758,454.645,458.076,464.98,467.401,470.288,475.237,478.656,486.026,490.975,494.427,497.314,500.708,505.658,508.545,511.933,514.82,519.77,523.688,527.07,532.019,535.471,539.39,543.873,546.294,551.243,556.193,559.645,563.069,566.521,570.439,575.388,580.338,583.79,586.677" y="521.9200000000001" svg_rhmargin="590.129" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">This result was consistent with most of the previous reports</text>
  <text x="345.091,348.543,353.492,357.975,362.459,366.377,369.829,372.716,375.137,380.086,384.569,388.8,391.687,396.636,401.119,404.00600000000003,408.245,412.728,417.677,420.565,424.483,427.935,430.356,435.305,438.757,443.053,446.505,450.423,454.906,462.277,466.195,471.144,474.031,478.258,482.741,487.691,490.578,492.999,495.886,502.324,507.74,514.644,519.593,523.895,528.378,533.328,540.698,543.119,548.068,550.489,553.941,556.828,560.28,564.763,567.651,570.071,575.021,579.9699999999999,584.27,586.691" y="532.918" svg_rhmargin="590.143" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">suggesting that anterior segment anti-VEGF administration is</text>
  <text x="345.091,348.543,353.026,355.913,359.831,362.252,364.819,372.288,377.237,379.842,383.761,386.648,389.253,393.737,396.158,398.777,401.665,406.614,411.563,416.513,421.462,424.062,426.949,430.401,435.35,442.72,445.321,448.208,453.157,457.075,459.496,462.948,465.559,472.93,476.848,479.735,484.218,487.105,491.589,496.538,501.021,503.442,507.925,511.377,513.798,517.25,519.869,522.756,527.706,532.189,535.0759999999999,537.727,540.615,545.564,549.482,552.934,556.852,559.44,566.344,570.262,573.714,577.6320000000001,580.246,585.195" y="543.8589999999999" svg_rhmargin="590.144" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">safe. Hu et al found from their meta-analysis that there were no</text>
  <text x="345.091,348.543,351.43,355.913,358.8,361.221,364.673,367.56,369.981,373.9,378.383,380.804,383.224,387.707,391.351,394.803,397.224,401.707,406.656" y="554.8009999999999" svg_rhmargin="409.077" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">statistically signi</text>
  <text x="409.098" y="554.8009999999999" svg_rhmargin="414.047" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="414.086,418.005,422.488,427.437,430.324,433.929,438.878,441.299,444.186,447.074,450.992,454.444,458.362,463.311,467.23,471.148,474.6,478.318,480.738,485.687,489.316,492.203,497.152,501.07,504.736,509.685,513.604,517.522,522.471,525.923,529.375,533.294,538.243,542.161,546.079,549.692,554.641,557.5279999999999,561.2,565.119,570.068,577.438,582.388,584.809,587.229" y="554.8009999999999" svg_rhmargin="590.116" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cant differences in the occurrence of compli-</text>
  <text x="345.091,349.009,353.492,356.379,358.8,363.75,368.699,372.151,374.117,379.066,382.984,385.871,392.775,396.694,400.612,405.56100000000004,407.564,410.452,415.401,419.319,421.284,426.233,430.151,434.635,439.118,443.036,445.457,449.375,454.325,461.695,466.178,471.127,473.156,477.639,481.091,486.04,490.99,495.939,497.93,502.413,507.362,512.311,514.256,517.143,522.093,526.011,528.032,531.95,536.9,541.849,544.736,548.188,553.138,555.5590000000001,557.511,561.995,565.447,570.396,575.345,580.294,582.285,587.235" y="565.742" svg_rhmargin="590.122" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cations between the bevacizumab group and the control group of</text>
  <text x="345.091,350.04,354.523,357.411,359.831,363.75,368.699,371.586,375.038,381.6,388.504,390.925,393.812,398.761,405.297,410.246,413.133,417.052,420.504,424.987,429.47,431.891,436.84,444.211,446.632,453.258,458.207,463.156,466.043,472.59,475.477,480.426,484.345,487.797,491.71500000000003,498.271,505.175,509.658,513.11,519.701,524.184,530.699,535.649,538.07,542.553,547.502,551.421,554.873,561.426,564.878,567.299,570.751,575.6999999999999,582.289,587.238" y="576.74" svg_rhmargin="590.125" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">patients with pterygium, but there was a higher risk of</text>
  <text x="345.091,348.543,353.492,358.442,362.36,367.309,372.259,374.68,379.629,384.578,388.497,391.384,393.805,398.288,402.771,405.192,409.888,414.838,418.756,426.126,431.076,434.528,437.98,442.929,447.412,451.896,455.814,458.235,462.951,465.838,468.725,473.439,475.86,479.312,483.984,486.871,491.821,496.77,501.72,506.66900000000004,511.366,516.316,521.265,524.1519999999999,528.884,531.771,536.72,541.204,544.0909999999999,548.783,553.266,558.215,561.102,563.523,566.411,572.848,578.264,585.168" y="587.682" svg_rhmargin="590.117" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">subconjunctival hemorrhage. It is found out that anti-VEGF</text>
  <text x="345.091,347.978,351.43,355.348,359.831,362.719,370.089,374.007,378.957,381.844,386.532,393.902,398.386,402.869,407.564,412.514,416.432,421.114,424.566,426.987,430.439,435.38800000000003,440.106,442.993,447.476,451.394,454.282,459.231,462.683,467.374,470.261,475.211,478.663,483.361,487.279,492.229,497.178,499.599,504.548,509.498,513.416,516.303,518.724,523.207,527.69,530.1110000000001,534.837,539.32,542.772,547.255,550.142,553.029,557.74,560.161,563.613,567.531,572.481,576.399,583.769,586.19" y="598.624" svg_rhmargin="590.108" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">treatment may be risk factor for conjunctival graft ischemic</text>
  <text x="345.091,349.574,354.523,359.007,362.925,366.377,369.829,373.747,376.271,380.189,384.673,388.591,393.54,396.427,399.879,402.406,404.827,409.776,412.271,417.22,422.17,425.622,428.145,431.597,434.484,439.433,444.383,448.866,451.287,453.826,459.242,463.725,468.674,473.157,476.609,479.11,483.028,485.915,488.465,492.948,495.36899999999997,497.876,501.794,506.743,511.693,516.642,521.592,525.51,528.397,532.315,537.264,539.827,544.31,546.8,551.75,555.202,560.151,563.603,568.553,572.471,576.389,579.276,581.697,586.18" y="609.6220000000001" svg_rhmargin="590.098" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">adverse events in our study. Bahar et al conducted a prospective</text>
  <text x="345.091,349.574,354.523,359.47200000000004,361.475,365.393,370.343,375.292,378.744,382.662,386.581,391.53,394.417,396.838,401.321,405.23900000000003,407.338,410.79,413.677,418.626,423.576,428.059,430.071,432.492,437.44100000000003,439.482,444.431,449.38,451.444,455.362,459.845,463.763,467.215,469.245,476.149,478.569,481.457,486.406,488.463,492.381,497.331,500.783,505.732,509.65,514.133,516.5540000000001,518.623,523.572,527.491,532.44,536.923,541.406,544.858,548.777,553.726,556.147,560.63,564.082,566.503,570.421,574.904,577.792,580.212,585.162" y="620.563" svg_rhmargin="590.111" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">and consecutive study in 10 eyes with corneal neovascularization</text>
  <text x="345.091,350.04,354.99,358.908,361.644,364.532,369.481,372.303,376.786,381.269,384.721,387.142,392.091,397.041,400.493,403.256,408.206,410.626,414.078,417.997,422.48,425.932,429.85,433.302,435.723,438.574,444.456,449.406,453.324,456.776,460.694,463.462,468.412,472.895,475.782,478.203,482.121,487.07,489.958,493.41,496.23,499.682,503.6,507.518,511.436,513.857,518.34,522.259,527.208,530.017,533.469,538.419,543.368,547.286,552.236,557.185,559.606,564.555,569.505,573.423,576.31,578.731,583.214,587.698" y="631.505" svg_rhmargin="590.119" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">due to various diseases. These patients received subconjunctival</text>
  <text x="345.091,347.512,352.461,354.882,358.8,362.719,365.606,368.027,372.976,377.925,382.564,387.513,390.4,394.979,399.929,402.35,407.29900000000004,408.415,415.786,420.269,422.69,427.639,430.06,435.009,436.194,443.564,448.97900000000004,453.542,458.491,462.41,466.893,471.376,475.294,477.715,481.633,486.583,493.953,498.436,503.385,508.022,510.909,515.859,519.311,523.952,528.901,533.477,540.381,544.3,548.218,553.167,556.619,561.256,565.739,570.688,575.637,580.247,585.197" y="642.5029999999999" svg_rhmargin="590.146" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">injection of 2.5 mg/0.1 mL bevacizumab for 2 weeks and no</text>
  <text x="345.091,349.574,354.523,359.007,362.925,366.377,369.829,373.747,377.008,380.926,385.41,389.328,394.277,397.164,400.616,403.88,410.784,414.703,418.155,422.073,425.366,430.316,435.265,438.717,442.635,446.087,450.57,454.489,459.438,462.725,467.675,472.624,476.076,478.497,483.446,487.92900000000003,491.184,494.071,499.021,502.939,506.207,509.094,514.044,516.465,518.886,523.835,530.739,533.626,538.576,543.525,546.798,549.685,552.106,559.476,563.394,566.697,571.646,574.5329999999999,577.809,582.758,585.179" y="653.444" svg_rhmargin="590.128" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">adverse events were observed during the follow-up time of 3.5</text>
  <text x="345.091,352.461,357.411,362.36,365.247,370.196,373.648,376.069,380.75,386.165,388.586,393.536,397.454,404.358,406.779,410.231,414.149,416.57,421.34,428.244,432.727,436.18,439.067,441.488,445.406,448.858,453.807,456.228,460.967,464.885,467.772,472.475,476.958,479.379,484.097,486.984,491.934,496.883,501.833,506.78200000000004,511.536,514.423,519.372,523.856,526.7429999999999,531.435,534.322,537.774,541.692,546.175,549.063,556.433,560.351,565.301,568.188,572.933,579.837,582.258,585.145" y="664.386" svg_rhmargin="590.094" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">months. Likewise, Dastjerdi et al found that treatment with</text>
  <text x="345.091,347.978,352.927,357.877,360.298,364.216,368.699,371.12,372.756,377.706,381.624,386.107,390.59,394.509,396.93,400.848,405.797,413.167,417.651,422.6,424.288,429.238,434.187,444.81,447.698,452.647,456.099,457.793,462.742,464.37,471.274,475.192,479.11,484.06,487.512,489.2,491.621,496.57,498.271,503.221,508.17,509.779,513.698,518.181,522.099,525.551,527.24,534.144,536.565,539.452,544.401,546.062,549.514,552.401,556.884,561.833,564.254,568.172,569.872,576.309,583.68" y="675.384" svg_rhmargin="590.118" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">topical bevacizumab 10%for 3 weeks in 10 eyes with stable CNV</text>
  <text x="345.091,351.995,356.478,359.93,362.268,369.173,373.091,375.512,377.933,380.296,383.183,388.133,390.554,394.472,397.924,402.407,405.294,409.212,414.162,416.58299999999997,418.96,427.926,432.875,436.327,439.214,441.522,446.472,449.359,451.727,454.614,459.564,463.482,465.844,470.327,475.276,479.759,483.678,487.13,490.582,494.5,496.854,500.772,505.255,509.173,514.123,517.01,520.462,522.818,529.722,533.641,537.093,541.011,543.34,547.259,552.208,557.157,559.578,564.528,569.477,573.395,576.282,578.703,583.187,587.67" y="686.326" svg_rhmargin="590.091" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">was well tolerated. Most of the adverse events were conjunctival</text>
  <text x="345.091,350.04,352.461,355.913,360.863,364.315,369.264,373.182,376.634,380.086,382.791,385.678,390.627,395.11,397.997,400.705,408.076,412.559,417.04200000000003,419.811,424.76,429.709,433.627,436.308,439.195,444.144,446.852,449.739,454.689,458.607,461.365,463.786,468.735,471.156,475.074,478.993,481.88,484.301,489.25,494.199,496.967,501.916,505.368,510.317,514.236,518.154,523.103,528.053,531.505,535.423,537.844,540.562,543.449,548.398,551.285,555.204,558.656,562.574,566.026,568.913,571.334,576.283,580.766,583.187,587.671" y="697.267" svg_rhmargin="590.092" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">disorders that may due to the injection procedure. Interestingly,</text>
  <text x="345.091,347.978,352.927,356.845,358.527,361.979,364.4,368.883,373.832" y="708.2090000000001" svg_rhmargin="376.253" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the signi</text>
  <text x="376.272" y="708.2090000000001" svg_rhmargin="381.221" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="381.204,385.123,389.606,394.555,397.442,399.176,404.125,406.546,409.433,412.32,416.238,419.69,423.609,428.558,432.476,436.394,438.122,445.027,449.51,452.962,454.676,459.625,464.575,467.462,469.132,472.02,476.969,481.918,486.868,491.817,493.51,498.459,503.409,506.296,508.023,510.444,515.393,517.094,519.981,524.931,528.849,530.53,533.982,538.932,543.881,548.364,551.816,556.766,561.715,566.664,568.399,573.349,577.832,581.284,585.202" y="708.2090000000001" svg_rhmargin="590.151" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cant difference was not found out in the subgroup based</text>
  <text x="345.091,350.04,354.98900000000003,359.944,364.428,369.377,376.747,379.168,384.118,386.538,389.991,392.878,396.33,400.813,403.7,406.121,411.07,416.019,421.057,424.509,429.458,434.408,437.295,441.213,443.634,448.666,453.615,458.565,461.452,466.467,468.888,473.837,478.826,481.713,486.663,490.581,495.606,499.058,504.008,508.957,513.44,516.892,521.842,526.791,531.74,536.708,541.657,546.141,549.593,553.511,558.4599999999999,563.466,568.415,573.3639999999999,578.376,581.263,586.213" y="719.207" svg_rhmargin="590.131" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">on administration route, but in the subgroup based on the</text>
  <path d=" M 85.03900146484375 766.885009765625 L 590.1729736328125 766.885009765625 L 590.1729736328125 767.6220092773438 L 85.03900146484375 767.6220092773438 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 85.03900146484375 337.09600830078125 L 590.1729736328125 337.09600830078125 L 590.1729736328125 337.8330078125 L 85.03900146484375 337.8330078125 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="108.567" y="40.202" height="377.064" width="458.079" title="7"/>
  <text x="108.567" y="40.202" class="image" id="image.7.1" width="458" height="377">image.7.1.109_567.40_417</text>
  <text svg_rhmargin="114.767" x="85.039,89.396,91.183,95.54,99.814,102.378,106.503,108.626,112.75,114.767" y="428.321" style="fill:#171615;font-family:DPNDMJ+AdvOTf94803d4;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Figure 4. </text>
  <text svg_rhmargin="174.869" x="118.488,122.456,126.58,128.912,132.722,136.301,138.475,140.597,144.871,146.193,150.318,152.49200000000002,154.542,156.41,160.535,162.86599999999999,164.916,167.09,171.058,174.869" y="428.321" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Forest plot for the </text>
  <text x="176.995" y="428.321" svg_rhmargin="180.26" style="fill:#171615;font-family:DPNDFO+AdvOT6e5d2ec0+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="180.226,183.805,187.616,191.89,194.682,198.493,200.361,202.229,206.039,209.85,212.024,215.603,217.698,223.839,227.964,232.238,236.048,237.371,239.409,241.583,245.708,247.799,251.61,255.189,258.768,262.578,266.157,269.736,271.835,274.009,277.977,281.78799999999995,283.854,287.432,291.243,293.111,296.922,299.096,302.51800000000003,304.602,308.726,310.594,312.652,316.463,320.43,322.604,326.415,328.746,330.069,334.193,336.524,338.615,342.194,346.005,350.129,356.271,360.156,364.124,366.298,368.376,372.344,375.923,379.734,381.756,385.88,387.748,389.863,393.673,397.641,399.815,401.137,403.857,408.213,412.569,418.091,422.059,424.159,426.333,428.664,432.475,436.285,438.46,444.602,448.412,452.38,454.554,456.641,457.963,461.93100000000004,464.011,466.185,470.153,473.964,476.029,479.84,483.964,486.296,490.263,494.074,497.884,499.901,501.992,508.135,511.946,514.12,517.93,520.65,524.555,528.522,532.333,533.656,537.078,540.657,541.979,545.558,547.627,551.438,554.86,558.67,559.993,563.96,567.771,569.945,573.756,578.03,580.166,582.34,586.308" y="428.321" svg_rhmargin="590.119" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">xed-effects model to assess the safety of anterior segment use of anti-VEGF treatment in the cornea. Meta-analysis evaluated the</text>
  <text x="85.039,89.164,93.438,97.712,101.291,102.783,105.114,108.925,111.099,112.421,116.546,120.125,121.603,123.389,128.911,133.887,137.466,139.252,140.707,144.832,146.7,148.19,152.001,156.125,158.457,162.424,166.235,170.045,171.368,172.85,176.66,180.934,182.257,184.431,188.398,192.209,193.531,194.854,198.978,203.252,207.063,209.237,213.205,216.627,218.143,222.267,224.59799999999998,226.079,229.89,232.221,236.346,239.925,241.247,245.372,249.339,251.356,252.836,256.647,260.92,262.243,264.417,268.385,272.195,273.518,274.84,278.651,279.974,281.463,285.737,289.548,291.416,295.226,299.037,301.211,303.228,304.705,308.516,312.64,314.971,318.939,322.75,326.56,327.883,329.364,333.332,334.654,338.465,342.276,344.607,346.624,348.128,351.939,355.906,360.18,361.677,365.487,369.455,373.729,377.853,380.028,383.995,387.806,389.128,390.451,394.261,395.584,397.05,398.918,403.042,404.365,408.639,410.656,412.129,416.253,420.221,424.032,425.508,429.087,433.36,437.328,441.139,443.47,447.281,448.75,450.536,454.115,455.437,458.859,462.67,466.944,468.478,472.752,475.083,479.207,483.481,487.606,489.937,492.111,493.434,497.558,501.526,505.336,506.659,507.981,511.403,512.921,515.13,519.255,520.722,522.897,526.864,530.6750000000001,532.117,535.696,537.87,541.838,546.112,549.534,550.994,556.516,560.327,561.649,565.847,569.814,571.9879999999999,573.443,574.766,578.7339999999999,580.19,582.364,586.332" y="437.279" svg_rhmargin="590.143" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">odds ratios (ORs) of corneal epitheliopathy or erosion, epithelial defect, corneal ulcer, and endothelial fold. The square (sized proportionally to the study weight in the</text>
  <text x="85.039,91.181,94.992,97.166,100.977,103.696,107.507,111.475,115.285,116.608,120.03,123.701,125.023,128.602,130.388,132.941,134.264,138.231,142.505,143.828,147.638,151.535,153.709,157.52,161.09900000000002,163.667,165.841,169.809,173.62,176.252,181.774,186.75,189.348,193.159,196.738,198.912,200.234,206.376,210.187,212.361,216.172,218.769,220.637,224.761,227.09199999999998,229.71,233.521,237.331,241.142,245.10999999999999,247.737,251.316,253.49,257.458,261.732,265.15400000000005,267.748,273.271,274.593,276.767,280.735,283.339,284.661,285.984,289.951,293.762,297.341,299.949,303.528,307.801,311.612,315.58,319.62,320.942,324.91,329.035,331.581,332.904,335.078,338.657,341.275,345.4,349.524,356.137,358.736,362.547,366.671" y="446.236" svg_rhmargin="370.639" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">meta-analysis) indicates the OR estimate for each study with lines spanning its 95% con</text>
  <text x="370.656" y="446.236" svg_rhmargin="373.921" style="fill:#171615;font-family:DPNDFO+AdvOT6e5d2ec0+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text svg_rhmargin="454.278" x="373.945,378.219,382.029,385.997,389.807,393.618,396.223,397.546,401.513,403.688,407.498,409.83,413.252,417.141,418.464,421.053,422.839,428.047,429.675,431.461,433.478,436.076,440.432,444.788,450.31,454.278" y="446.236" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">dence interval (CI). VEGF </text>
  <text x="455.242" y="446.236" svg_rhmargin="460.3" style="fill:#171615;font-family:DPNDGB+AdvOTb0c9bf5d;font-size:7.47px;font-style:NORMAL;font-weight:normal;">=</text>
  <text x="461.251,464.673,468.484,472.063,475.874,479.841,481.164,484.974,487.305,489.935,493.746,497.714,501.987,506.112,508.286,512.254,516.064,517.387,518.789,522.6,523.923,526.499,530.624,532.955,537.08,542.601,544.776,548.7439999999999,551.329,553.197,557.008,560.818,563.063,567.188,569.519,571.5360000000001,574.118" y="446.236" svg_rhmargin="575.747" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">vascular endothelial growth factor, I</text>
  <text svg_rhmargin="578.866" x="575.773,578.866" y="446.236" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:4.98px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text x="579.798" y="446.236" svg_rhmargin="584.856" style="fill:#171615;font-family:DPNDGB+AdvOTb0c9bf5d;font-size:7.47px;font-style:NORMAL;font-weight:normal;">=</text>
  <text x="585.808,587.437" y="446.236" svg_rhmargin="590.157" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">I-</text>
  <text x="85.042,88.621,92.895,96.862,100.673,103.004,106.815,111.089,113.613,117.581,121.391,123.566,127.445,129.776,133.901,138.025,141.836,145.803,149.614,150.936,153.111,156.533,159.02,162.599,164.773,168.657,170.832,172.154,175.733,177.907,179.23,183.041" y="455.193" svg_rhmargin="185.058" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.47px;font-style:NORMAL;font-weight:normal;">squared heterogeneity statistic.</text>
  <text x="85.039,90.595,94.827,98.892,103.124,107.523,110.154,114.218,116.537,119.168,123.233,124.643,126.795,129.429,135.98,140.045,144.604,146.015,150.079,151.49,155.722,159.787,162.366,164.271,168.671,173.07,177.47,181.869,183.774,186.403,190.802,195.202,197.354,201.753,206.152,517.041,522.931,528.821,534.711,536.863,543.414,547.973,550.874,552.285,556.685,560.917,563.3,567.532,571.597,573.008,575.16,579.224,583.624" y="9.870999999999981" svg_rhmargin="590.176" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Huang et al. Medicine (2018) 97:34 www.md-journal.com</text>
  <text x="335.396" y="739.625" svg_rhmargin="339.796" style="fill:#171615;font-family:DPNDMJ+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">7</text>
 </g>
</svg>
